Abstract
Overexpression and long terminal repeat (LTR) polymorphism of the HRES‑1/Rab4 human endogenous retrovirus locus have been associated with T cell activation and disease manifestations in systemic lupus erythematosus (SLE). Although genomic DNA methylation is diminished overall in SLE, its role in HRES-1/Rab4 expression is unknown. Therefore, we determined how lupus-associated polymorphic rs451401 alleles of the LTR regulate transcription from the HRES-1/Rab4 promoter and thus affect T cell activation. The results showed that cytosine-119 is hypermethylated while cytosine-51 of the promoter and the LTR enhancer are hypomethylated in SLE. Pharmacologic or genetic inactivation of DNA methyltransferase 1 augmented the expression of HRES-1/Rab4. The minimal promoter was selectively recognized by metabolic stress sensor NRF1 when cytosine-119 but not cytosine-51 was methylated, and NRF1 stimulated HRES-1/Rab4 expression in human T cells. In turn, IRF2 and PSIP1 bound to the LTR enhancer and exerted control over HRES-1/Rab4 expression in rs451401 genotype- and methylation-dependent manners. The LTR enhancer conferred markedly greater expression of HRES-1/Rab4 in subjects with rs451401CC over rs451401GG alleles that in turn promoted mechanistic target of rapamycin (mTOR) activation upon T cell receptor stimulation. HRES-1/Rab4 alone robustly activated mTOR in human T cells. These findings identify HRES-1/Rab4 as a methylation- and rs451401 allele-dependent transducer of environmental stress and controller of T cell activation.
Highlights
Systemic lupus erythematosus (SLE) is a potentially fatal autoimmune disease of unknown etiology
The present results delineate the genetic and epigenetic mechanism that controls HRES-1/Rab4 expression and reveal that mechanistic target of rapamycin (mTOR) pathway activation in human T cells is determined by polymorphism of the endogenous retroviral long terminal repeat (LTR)
The HRES-1/Rab4 promoter and LTR enhancer interact with remarkably different transcription factors (TFs)
Summary
Systemic lupus erythematosus (SLE) is a potentially fatal autoimmune disease of unknown etiology. Upon DNA demethylation, enhanced transcription of interferon-responsive genes involves activation of endogenous retroviral sequences (ERSs) [8] They make up as much as 8% of the human genome [9]. Polymorphic alleles of the retroviral long terminal repeat (LTR) are centered around a SNP, rs451401, which has been associated with autoimmunity and organ-specific manifestations in SLE [13, 14]. This SNP has been connected with susceptibility to multiple sclerosis [15,16,17,18,19,20]. HRES-1 encodes a GTPase, HRES-1/Rab, which is markedly overexpressed in T cells of SLE patients [21] and in lupus-prone mice before disease onset [22]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.